We are live on ! Find out more
PM

Parametrica Management Portfolio holdings

AUM $88M
1-Year Est. Return 48.84%
This Fund
S&P 500
This Quarter Est. Return
-4.28%
1 Year Est. Return
+48.84%
3 Year Est. Return
+257.17%
5 Year Est. Return
+315.15%
10 Year Est. Return
–
AUM
$27.9M
AUM Growth
+$12.7M
Cap. Flow
+$12.2M
Cap. Flow %
43.59%
Top 10 Hldgs %
17.59%
Holding
150
New
90
Increased
7
Reduced
6
Closed
47

Top Buys

Rank Stock Value
1
INSY
Insys Therapeutics, Inc.
INSY
+$637K
2
LYV icon
Live Nation Entertainment
LYV
+$625K
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$462K
4
WAL icon
Western Alliance Bancorporation
WAL
+$461K
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$460K

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$519K
2
TRCO
TRIBUNE MEDIA COMPANY CLASS A
TRCO
+$510K
3
ESPR
Esperion Therapeutics
ESPR
+$443K
4
MUSA icon
Murphy USA
MUSA
+$440K
5
DGI
DigitalGlobe Inc.
DGI
+$374K

Sector Composition

Rank Sector Weight
1 Technology 21.97%
2 Consumer Discretionary 13.09%
3 Healthcare 12.68%
4 Industrials 11.61%
5 Financials 10.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MLCO icon
51
Melco Resorts & Entertainment
MLCO
$2.21B
$241K 0.86%
+14,567
New +$221K
DBD
52
DELISTED
Diebold Nixdorf Incorporated
DBD
$241K 0.86%
+8,345
New +$218K
CATM
53
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$241K 0.86%
+6,685
New +$219K
C icon
54
Citigroup
C
$213B
$238K 0.85%
+5,700
New +$238K
AZO icon
55
AutoZone
AZO
$51.3B
$237K 0.85%
+298
New +$225K
ORCL icon
56
Oracle
ORCL
$339B
$236K 0.85%
+5,768
New +$213K
BKNG icon
57
Booking.com
BKNG
$156B
$235K 0.84%
+4,550
New +$218K
NDSN icon
58
Nordson
NDSN
$16.4B
$234K 0.84%
+3,077
New +$203K
PFPT
59
DELISTED
Proofpoint, Inc.
PFPT
$233K 0.84%
+4,326
New +$221K
XPO icon
60
XPO
XPO
$23.4B
$232K 0.83%
+21,894
New +$191K
APOG icon
61
Apogee Enterprises
APOG
$833M
$229K 0.82%
+5,225
New +$207K
HIMX
62
Himax Technologies
HIMX
$2.03B
$229K 0.82%
+20,396
New +$179K
MRVL icon
63
Marvell Technology
MRVL
$147B
$226K 0.81%
+21,959
New +$202K
SNCR
64
DELISTED
Synchronoss Technologies
SNCR
$221K 0.79%
+759
New +$198K
MRD
65
DELISTED
MEMORIAL RESOURCE DEV CORP COM STK (DE)
MRD
$221K 0.79%
+21,753
New +$257K
SON icon
66
Sonoco
SON
$5.83B
$220K 0.79%
+4,527
New +$193K
EFII
67
DELISTED
Electronics for Imaging
EFII
$220K 0.79%
+5,197
New +$212K
PNC icon
68
PNC Financial Services
PNC
$99.1B
$219K 0.79%
+2,584
New +$220K
TERP
69
DELISTED
TerraForm Power, Inc
TERP
$218K 0.78%
+25,195
New +$235K
LUMO
70
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$216K 0.77%
+1,317
New +$267K
FNSR
71
DELISTED
Finisar Corp
FNSR
$216K 0.77%
11,830
-21,897
-65% -$315K
BMRN icon
72
BioMarin Pharmaceuticals
BMRN
$11.9B
$215K 0.77%
+2,609
New +$212K
NKE icon
73
Nike
NKE
$64.1B
$215K 0.77%
+3,503
New +$212K
KMB icon
74
Kimberly-Clark
KMB
$37.6B
$214K 0.77%
+1,592
New +$207K
LM
75
DELISTED
Legg Mason, Inc.
LM
$213K 0.76%
+6,133
New +$192K
1 2
3
4 5

Similar funds

BCP
Balance Capital Partners New York $87.9M AUM
PBCM
Point Break Capital Management Miami, Florida $88M AUM
CVM
Civilization Ventures Management Belvedere Tiburon, California $87.9M AUM
XXIP
Xiamen Xinweidachuang Investment Partnership Xiamen, China $87.8M AUM 29.25% 1-Year Est. Return
DG
Daventry Group New York $87.8M AUM 3.83% 1-Year Est. Return
RFL
RD Finance Ltd Limassol, Cyprus $88.1M AUM 11.44% 1-Year Est. Return
IAP
Indie Asset Partners Carmel, Indiana $87.8M AUM 27.76% 1-Year Est. Return
MPEM
Marathon Partners Equity Management New York $88.3M AUM 20.65% 1-Year Est. Return

Parametrica Management's Q1 2016 Portfolio in Review

As of Q1 2016, Parametrica Management held 150 positions worth $27.9M, up 84% from $15.2M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Parametrica Management deployed $12.2M of net new capital in Q1 2016, opening 90 new positions and adding to 7 existing holdings. Its largest new stake was Insys Therapeutics, Inc.: 33,562 shares worth $537K.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Finisar Corp, an estimated $315K trimmed.

  • Parametrica Management's largest Q1 2016 buy was Insys Therapeutics, Inc.: 33,562 shares worth $537K.
  • Parametrica Management added most to CNH Industrial in Q1 2016, an estimated $424K increase.
  • Parametrica Management's biggest Q1 2016 reduction was Finisar Corp, cutting an estimated $315K.
  • Parametrica Management fully exited PTC Therapeutics in Q1 2016, selling an estimated $519K.
  • Parametrica Management's ten largest holdings make up 18% of its $27.9M portfolio in Q1 2016.
  • Parametrica Management opened 90 new positions and closed 47 in Q1 2016.
  • Parametrica Management's portfolio value rose 84% quarter-over-quarter to $27.9M.

Based on Parametrica Management's 13F filing for Q1 2016, filed 5 May 2016.